These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
312 related items for PubMed ID: 26585557
1. Flubromazolam--A new life-threatening designer benzodiazepine. Łukasik-Głębocka M, Sommerfeld K, Teżyk A, Zielińska-Psuja B, Panieński P, Żaba C. Clin Toxicol (Phila); 2016; 54(1):66-8. PubMed ID: 26585557 [Abstract] [Full Text] [Related]
2. Detectability of designer benzodiazepines in CEDIA, EMIT II Plus, HEIA, and KIMS II immunochemical screening assays. Pettersson Bergstrand M, Helander A, Hansson T, Beck O. Drug Test Anal; 2017 Apr; 9(4):640-645. PubMed ID: 27366870 [Abstract] [Full Text] [Related]
3. Occurrence and time course of NPS benzodiazepines in Sweden - results from intoxication cases in the STRIDA project. Bäckberg M, Pettersson Bergstrand M, Beck O, Helander A. Clin Toxicol (Phila); 2019 Mar; 57(3):203-212. PubMed ID: 30348014 [Abstract] [Full Text] [Related]
4. Human urinary metabolic patterns of the designer benzodiazepines flubromazolam and pyrazolam studied by liquid chromatography-high resolution mass spectrometry. Pettersson Bergstrand M, Meyer MR, Beck O, Helander A. Drug Test Anal; 2018 Mar; 10(3):496-506. PubMed ID: 28677876 [Abstract] [Full Text] [Related]
5. Blood concentrations of new designer benzodiazepines in forensic cases. Høiseth G, Tuv SS, Karinen R. Forensic Sci Int; 2016 Nov; 268():35-38. PubMed ID: 27685473 [Abstract] [Full Text] [Related]
6. Designer benzodiazepines' pharmacological effects and potencies: How to find the information. El Balkhi S, Monchaud C, Herault F, Géniaux H, Saint-Marcoux F. J Psychopharmacol; 2020 Sep; 34(9):1021-1029. PubMed ID: 31971477 [Abstract] [Full Text] [Related]
7. Flubromazolam - Basic pharmacokinetic evaluation of a highly potent designer benzodiazepine. Huppertz LM, Moosmann B, Auwärter V. Drug Test Anal; 2018 Jan; 10(1):206-211. PubMed ID: 28378533 [Abstract] [Full Text] [Related]
9. Overdose from designer benzodiazepine Diclazepam. Runnstrom M, Kalra SS, Lascano J, Patel DC. QJM; 2020 Feb 01; 113(2):122-124. PubMed ID: 31593281 [No Abstract] [Full Text] [Related]
10. In vitro glucuronidation of designer benzodiazepines by human UDP-glucuronyltransferases. Pettersson Bergstrand M, Richter LHJ, Maurer HH, Wagmann L, Meyer MR. Drug Test Anal; 2019 Jan 01; 11(1):45-50. PubMed ID: 29996009 [Abstract] [Full Text] [Related]
13. In vitro studies on flubromazolam metabolism and detection of its metabolites in authentic forensic samples. Noble C, Mardal M, Bjerre Holm N, Stybe Johansen S, Linnet K. Drug Test Anal; 2017 Aug 01; 9(8):1182-1191. PubMed ID: 27935260 [Abstract] [Full Text] [Related]
14. Validation of an LC-MS/MS Method for the Quantification of 13 Designer Benzodiazepines in Blood. Mei V, Concheiro M, Pardi J, Cooper G. J Anal Toxicol; 2019 Oct 17; 43(9):688-695. PubMed ID: 31436813 [Abstract] [Full Text] [Related]
16. Blood Concentrations of Designer Benzodiazepines: Relation to Impairment and Findings in Forensic Cases. Heide G, Høiseth G, Middelkoop G, Øiestad ÅML. J Anal Toxicol; 2020 Dec 12; 44(8):905-914. PubMed ID: 32369173 [Abstract] [Full Text] [Related]
17. Clonazolam a new designer benzodiazepine intoxication confirmed by blood concentration. Sommerfeld-Klatta K, Łukasik-Głębocka M, Teżyk A, Panieński P, Żaba C, Zielińska-Psuja B. Forensic Sci Int; 2020 May 12; 310():110237. PubMed ID: 32172178 [Abstract] [Full Text] [Related]
18. A Case Study Involving U-47700, Diclazepam and Flubromazepam-Application of Retrospective Analysis of HRMS Data. Partridge E, Trobbiani S, Stockham P, Charlwood C, Kostakis C. J Anal Toxicol; 2018 Nov 01; 42(9):655-660. PubMed ID: 29945197 [Abstract] [Full Text] [Related]
20. Rhabdomyolysis in the Context of Designer Benzodiazepine Misuse. Noe G, Shah K, Quattlebaum T, Munjal S. Cureus; 2023 Dec 01; 15(12):e50741. PubMed ID: 38234935 [Abstract] [Full Text] [Related] Page: [Next] [New Search]